Jeffrey S. Cluver, MD, Tara M. Wright, MD, and Hugh Myrick, MD CHAPTER48 While the properties of benzodiazepines and barbiturates are similar, the relative safety and tolerability of the benzodiazepines…
Summary by Daniel Eckroth, MD CHAPTER47 Based on “Principles of Addiction Medicine” Chapter by Hugh Myrick, MD, Henry R. Kranzler, MD, Domenic A. Ciraulo, MD, Andrew J. Saxon, MD, and…
Summary by Jon E. Grant, MD, JD, MPH, and Brian L. Odlaug, MPH CHAPTER39 Based on “Principles of Addiction Medicine” Chapter by Jon E. Grant, MD, JD, MPH, Brian L….
Summary by Andrew O’Hagan, MD CHAPTER28 Based on “Principles of Addiction Medicine” Chapter by Karran A. Phillips, MD, MSc, Peter D. Friedmann, MD, MPH, FASAM, FACP, Richard Saitz, MD, MPH,…
A. Thomas McLellan, PhD CHAPTER25 THE CONCEPTUAL AND HISTORICAL BASIS FOR THE EXISTING ADDICTION TREATMENT SYSTEM Over the past two decades, research evidence of significant genetic heritability and persistent brain…
Andrea G. Barthwell, MD, FASAM, and Lawrence S. Brown, Jr, MD, MPH, FASAM CHAPTER24 GOALS OF SUBSTANCE USE TREATMENT In the United States, over 11,000 specialized substance use treatment facilities…
Mark L. Willenbring, MD CHAPTER23 DEVELOPMENT OF MODERN TREATMENT APPROACHES Professional treatment for alcohol use disorder (AUD) supported by basic and clinical research is a relatively new field that for…
William L. White, MA, and James F. Callahan, DPA CHAPTER22 THE BIRTH OF ADDICTION MEDICINE The roots of addiction medicine began not in a young America but in the ancient…
Edward F. Domino, MD, and Shannon C. Miller, MD, FASAM, DFAPA CHAPTER15 DEFINITION (DRUGS IN THIS CLASS) Dissociatives should be distinguished pharmacologically and clinically from true hallucinogens. A simplified view…
Torsten Passie, MD, MA, and John H. Halpern, MD CHAPTER14 DEFINITION Hallucinogen is the most widely accepted term for a group of chemically divergent substances primarily used for their potential…
